AGP Picks
View all

Health Wire Syria
Provided by AGP

Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 23, 2026

Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 ($55,000 CAD based on current exchange rate) research grant to advance microbiota research in human health & disease
Jun. 23, 2026

Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 ($55,000 CAD based on current exchange rate) research grant to advance microbiota research in human health & disease

Indeterminate GlobeNewswire
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 € (55,000 $ CAD selon le taux de change actuel). L’objectif est de faire progresser l’étude …
Jun. 23, 2026

La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 35 000 € (55,000 $ CAD selon le taux de change actuel). L’objectif est de faire progresser l’étude …

Indeterminate GlobeNewswire
TogetherTuesday: Arizona Nonprofit Surpasses $6 Million for Childhood Blindness Research
Jun. 23, 2026

TogetherTuesday: Arizona Nonprofit Surpasses $6 Million for Childhood Blindness Research

Indeterminate GlobeNewswire
Dynacare Launches Canada's First At-Home, Self-Collect Hormone Blood Tests
Jun. 23, 2026

Dynacare Launches Canada's First At-Home, Self-Collect Hormone Blood Tests

Indeterminate GlobeNewswire
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
Jun. 23, 2026

GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma

Indeterminate GlobeNewswire
GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraités
Jun. 23, 2026

GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraités

Indeterminate GlobeNewswire
RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun. 23, 2026

RESTEM to Present at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Indeterminate GlobeNewswire
Frankie Muniz Is Having a Major Comeback — and HairClub Is Part of the Journey
Jun. 23, 2026

Frankie Muniz Is Having a Major Comeback — and HairClub Is Part of the Journey

Indeterminate GlobeNewswire
Strong at Every Age: How Women Can Help Combat Muscle Loss
Jun. 23, 2026

Strong at Every Age: How Women Can Help Combat Muscle Loss

Indeterminate GlobeNewswire
A Backyard Makeover Could Help Keep Ticks at Bay
Jun. 23, 2026

A Backyard Makeover Could Help Keep Ticks at Bay

Indeterminate GlobeNewswire
Boomer Benefits Unveils Updated Medicare Plan G Reviews Guide
Jun. 23, 2026

Boomer Benefits Unveils Updated Medicare Plan G Reviews Guide

Indeterminate GlobeNewswire
X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson's Disease Therapy
Jun. 23, 2026

X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson's Disease Therapy

Indeterminate GlobeNewswire
Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production
Jun. 23, 2026

Asimov Launches Chrysalis Transposase, a Wholly-Owned Genome Integration Tool for Biotherapeutics Production

Indeterminate GlobeNewswire
Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities
Jun. 23, 2026

Sigmatic Sciences Powers AI Scientists with NVIDIA’s Latest BioNeMo Agentic Capabilities

Indeterminate GlobeNewswire
New Anglia University: Trends Shaping the Future of Graduate Medical Education in the United States
Jun. 23, 2026

New Anglia University: Trends Shaping the Future of Graduate Medical Education in the United States

Indeterminate GlobeNewswire
ECM Therapeutics Receives FDA 510(k) Clearance for ECMT-100 WMD
Jun. 23, 2026

ECM Therapeutics Receives FDA 510(k) Clearance for ECMT-100 WMD

Indeterminate GlobeNewswire
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
Jun. 23, 2026

MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D

Indeterminate GlobeNewswire
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone
Jun. 23, 2026

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

Indeterminate GlobeNewswire
Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board
Jun. 23, 2026

Tria Federal Appoints Former CMS and IRS CIO Rajiv Uppal to Advisory Board

Indeterminate GlobeNewswire
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Jun. 23, 2026

Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Wire Syria

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.